Liu Pengshuai, Wei Junli, Chen Shubo
Department of Surgery, Graduate School of Chengde Medical College, Chengde, Hebei, China.
Department of Urology, Xingtai People's Hospital, Xingtai, Hebei, China.
Front Oncol. 2025 Aug 4;15:1580024. doi: 10.3389/fonc.2025.1580024. eCollection 2025.
To explore the factors associated with the immunohistochemical results in clear cell renal cell carcinoma (ccRCC).
This retrospective, single-center observational study included patients with pathologically confirmed ccRCC who underwent nephrectomy at Xingtai People's Hospital between January 2023 and October 2024. Logistic and linear regression was used to evaluate predictors of ccRCC features, with adjustments for demographic and clinical factors.
Among the 50 patients (median age, 66 years; 64% male), high Vimentin expression was significantly associated with vascular invasion (adjusted OR, 2.90; 95% CI, 1.05-7.62; P = 0.031), lymph node metastasis (OR, 2.62; 95% CI, 1.03-8.12; P = 0.042), distant metastasis (OR, 3.10; 95% CI, 1.01-12.54; P = 0.048), and larger tumor size (P = 0.004). Ki-67 expression varied significantly by alcohol consumption (P = 0.024), perineural invasion (P = 0.038), and was positively correlated with serum creatinine (P = 0.017). CD10 expression was inversely correlated with bilirubin levels (P = 0.021) but not associated with invasive or metastatic features.
Vimentin expression was strongly associated with markers of tumor invasiveness and may serve as a practical prognostic biomarker in ccRCC. Ki-67 may reflect proliferative activity and systemic burden. CD10 remains diagnostically useful but lacks prognostic value. Incorporating these IHC markers into routine pathology assessment may enhance risk stratification and inform individualized management of ccRCC with more exploration and validation.
探讨与透明细胞肾细胞癌(ccRCC)免疫组化结果相关的因素。
这项回顾性、单中心观察性研究纳入了2023年1月至2024年10月在邢台市人民医院接受肾切除术且病理确诊为ccRCC的患者。采用逻辑回归和线性回归评估ccRCC特征的预测因素,并对人口统计学和临床因素进行调整。
在50例患者中(中位年龄66岁;64%为男性),波形蛋白高表达与血管侵犯(校正OR,2.90;95%CI,1.05 - 7.62;P = 0.031)、淋巴结转移(OR,2.62;95%CI,1.03 - 8.12;P = 0.042)、远处转移(OR,3.10;95%CI,1.01 - 12.54;P = 0.048)及更大的肿瘤大小(P = 0.004)显著相关。Ki-67表达因饮酒情况(P = 0.024)、神经周围侵犯情况(P = 0.038)而有显著差异,且与血清肌酐呈正相关(P = 0.017)。CD10表达与胆红素水平呈负相关(P = 0.021),但与侵袭或转移特征无关。
波形蛋白表达与肿瘤侵袭标志物密切相关,可能作为ccRCC实用的预后生物标志物。Ki-67可能反映增殖活性和全身负担。CD10在诊断上仍有作用,但缺乏预后价值。将这些免疫组化标志物纳入常规病理评估可能会加强ccRCC的风险分层,并为个体化管理提供依据,还需要更多的探索和验证。